Close
What would you like to look for?

16 February 2017

Symetis acquired Middle Peak Medical, a private U.S. and German medical device company focused on developing minimally invasive novel solutions for unmet needs in the treatment of mitral valve regurgitation. The acquisition marks Symetis’ first expansion from the TAVI space into the broader structural heart segment. Symetis is a Swiss medical technology company specializing in the development, manufacturing and marketing of next-generation percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.

Symetis is advised as per Swiss law by VISCHER AG (Matthias Staehelin, Angelo Imperiale), as per German law by SNP Schlawien Partnerschaft mbB (Christian Ostermaier, Christine Lange and Friedrich Kötter-Boisserée) and as per US law by Cooley LLP (Ivor Elrifi and Barbara Bispham).

Categories: Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Deals & Cases

Author